Leading international competence recruited to the board of Hamlet Pharma
As previously announced, the Extraordinary General Meeting of Hamlet Pharma held on the 4[th ]of March, elected Professor Bill Hansson to the board of Hamlet Pharma.Bill Hansson was until recently Vice President of the Max Planck Society. In this capacity he facilitated the progress of science in Germany and internationally and during his leadership, the organization has flourished, as illustrated e.g. by the recent Nobel Prize awards. Bill Hansson has also overseen the translation of scientific innovations for public and commercial use and spearheaded a new human resources and